论文部分内容阅读
一、病例选择:分为以下四组。A 组:未经治疗的瘤型,均为典型瘤型,不是界线类。B 组:复发的瘤型病例。C 组:分 C_1和 C_2两组。C_1组:经5年以上常规化疗,但细菌指数下降不明显的瘤型病例。C_2组:经1年以上常规化疗,临床症状恶化的瘤型病例,但不包括反复发生麻风性结节性红斑者。D 组;眼症状恶化者,或可能引起失明者。对照组:选择与 A、B 相类似的病例做为 A、
First, the case selection: divided into the following four groups. Group A: untreated tumor type, are typical tumor type, not a borderline class. Group B: recurrent tumor type cases. Group C: divided C_1 and C_2 two groups. C_1 group: After more than 5 years of conventional chemotherapy, but not significantly decreased bacterial index tumor cases. C_2 group: more than 1 year conventional chemotherapy, clinical symptoms of malignant tumor cases, but does not include the recurrence of leprosy nodular erythema. Group D; those with worsening ocular symptoms or who may cause blindness. Control group: Select A and B similar cases as A,